Thrombolytic TherapyStreptokinaseTissue Plasminogen ActivatorFibrinolytic AgentsMyocardial InfarctionPlasminogen ActivatorsAnistreplaseUrokinase-Type Plasminogen ActivatorStrokePulmonary EmbolismBrain IschemiaTreatment OutcomeHeparinCerebral HemorrhageTime FactorsMyocardial ReperfusionEmbolectomyThrombosisAcute DiseaseCoronary Care UnitsFibrinolysisHeart Rupture, Post-InfarctionIntracranial ThrombosisHemorrhageElectrocardiographyIntracranial HemorrhagesAngioplasty, Balloon, CoronaryFibrinolysinProspective StudiesCarotid Artery ThrombosisInfusions, IntravenousCoronary ThrombosisCoronary AngiographyEmergency Medical ServicesRecurrenceRecombinant ProteinsIntracranial Embolism and ThrombosisInjections, IntravenousVascular PatencyEmergenciesTomography, X-Ray ComputedInfusions, Intra-ArterialIntracranial EmbolismVenous ThrombosisEmergency TreatmentCerebral InfarctionHirudin TherapyAnticoagulantsCreatine KinaseEmergency Medical TechniciansRadionuclide VentriculographyRetrospective StudiesHospital MortalityInjections, Intra-ArterialThrombectomyReperfusionFibrinopeptide AFollow-Up StudiesCerebral AngiographyFibrinogenFibrinEye HemorrhagePatient SelectionNewfoundland and LabradorHeart RuptureWorkRandomized Controlled Trials as TopicCatheterization, PeripheralSurvival AnalysisStreptodornase and StreptokinaseAspirinAngiographyRisk FactorsPredictive Value of TestsEcchymosisInfarction, Middle Cerebral ArteryCerebrovascular DisordersDrug Therapy, CombinationBlood CoagulationPrognosisArterial Occlusive DiseasesFibrin Fibrinogen Degradation ProductsHospitals, CommunityCardiac CatheterizationShock, CardiogenicVentricular Septal RupturePlasminogenInfarction, Anterior Cerebral ArteryRegistriesSurvival RateMultivariate AnalysisIliac VeinHemostasisVena Cava FiltersHirudinsCommunity MedicineThrombophlebitisPlatelet Aggregation InhibitorsVentricular Dysfunction, RightEmbolism